Home / Hair Loss

Dutasteride vs Finasteride Men: Which Works Better?

Written by James T.

Published March 30, 2026

For men with stubborn male pattern hair loss who have not responded to finasteride, dutasteride offers broader inhibition of the enzyme driving follicle miniaturization — but the choice between the two requires a careful look at the evidence and individual health history.

How These Drugs Work: The 5-Alpha Reductase Pathway

Male pattern hair loss — the medical term is androgenetic alopecia — is driven primarily by dihydrotestosterone (DHT), a potent androgen derived from testosterone. The conversion of testosterone to DHT is catalyzed by an enzyme called 5-alpha reductase, which exists in two main subtypes: Type 1 and Type 2.

Finasteride selectively inhibits Type 2 5-alpha reductase, the isoform most active in hair follicles and the prostate. Blocking this enzyme reduces scalp DHT by approximately 70%, which slows or halts follicle miniaturization in most men.

Dutasteride inhibits both Type 1 and Type 2 5-alpha reductase — a so-called dual inhibitor. This broader blockade reduces serum DHT by more than 90%, a measurably greater suppression than finasteride achieves. Whether that additional suppression translates into meaningfully better hair outcomes is exactly what the clinical trials address.

The Evidence Base

Finasteride

The pivotal evidence for finasteride in androgenetic alopecia comes from two large randomized controlled trials published in the *Journal of the American Academy of Dermatology* (Kaufman et al., 1998), involving more than 1,500 men aged 18–41 with vertex and anterior-mid scalp hair loss. After two years, men on 1 mg/day finasteride showed statistically significant increases in hair count versus placebo, with 83% maintaining or improving hair count at 12 months. The U.S. Food and Drug Administration approved finasteride 1 mg for male pattern hair loss in 1997. Results may vary.

Dutasteride

Dutasteride 0.5 mg is FDA-approved for benign prostatic hyperplasia (BPH, or prostate enlargement) but is used off-label for androgenetic alopecia in the United States. It is approved specifically for hair loss in South Korea and Japan. A pivotal 24-week randomized controlled trial published in the *Journal of the American Academy of Dermatology* (Olsen et al., 2006, with additional data through Eun et al., 2010) compared dutasteride 0.5 mg/day against finasteride 1 mg/day and placebo in men with vertex hair loss. Dutasteride produced statistically greater increases in total and target area hair counts compared with finasteride at week 24. Results may vary.

A subsequent network meta-analysis of 23 randomized controlled trials, published in [JAMA Dermatology](https://pubmed.ncbi.nlm.nih.gov/30785708/) (Mella et al., 2019), ranked dutasteride 0.5 mg as the most efficacious oral agent for androgenetic alopecia based on hair count outcomes, placing it above finasteride 1 mg. The authors noted that head-to-head trial data remain limited, and longer-term comparative studies are needed. We don't yet know whether the hair-count advantage seen at 24 weeks is sustained at five or ten years at the same magnitude.

Who Is — and Is Not — a Candidate

Potentially appropriate candidates (as determined by a licensed provider): - Men with documented androgenetic alopecia who have not responded adequately to finasteride after 12 months of consistent use - Men who have not previously tried a 5-alpha reductase inhibitor and present with moderate-to-severe vertex thinning - Men with no history of prostate cancer or elevated prostate-specific antigen (PSA) concerns not yet evaluated

Relative contraindications and cautions your provider will assess: - Prostate cancer history or monitoring: Both drugs lower PSA, which can mask early cancer signals. Baseline PSA and provider awareness are essential. - Liver disease: Both drugs are hepatically metabolized; caution is warranted. - Planned fatherhood: Both agents may reduce semen volume and motility; discuss fertility intentions explicitly with your provider before starting. - Allergy or sensitivity to either compound. - Dutasteride's long half-life: Dutasteride remains in the bloodstream for up to five weeks after the last dose — far longer than finasteride's six-to-eight hours. This matters for side-effect monitoring and for any planned fertility window.

Neither drug is appropriate for women of childbearing potential, and this article addresses only adult male patients.

What to Expect on Treatment

Timeline: Neither drug works overnight. Most men taking finasteride notice stabilization of shedding within three to six months and visible regrowth, if it occurs, between six and twelve months. Dutasteride data suggest a similar or slightly faster onset, but patience is required regardless.

Common side effects (reported in a minority of users, results may vary): - Decreased libido, erectile dysfunction, or reduced ejaculate volume — collectively termed post-treatment sexual side effects — occurred in roughly 1–2% of finasteride users in clinical trials and at comparable or slightly higher rates with dutasteride. - Breast tenderness or mild gynecomastia (breast tissue growth) is an uncommon but recognized effect of both agents. - Mood changes, including depressed mood, have been reported; the causal relationship remains under investigation.

When to contact your provider immediately: new or worsening depression, any breast lump, significant change in urinary function, or signs of an allergic reaction (hives, facial swelling, difficulty breathing). Direct clinical questions to your licensed provider through the patient portal — not to customer support.

The Good Guy Rx Pathway

Good Guy Rx is a technology platform that connects men to independent licensed physicians and independent state-licensed pharmacies. If you are experiencing male pattern hair loss and want to know whether finasteride — or a discussion of dutasteride — is clinically appropriate for you, the prescribing provider determines candidacy after a thorough medical intake that includes your health history, current medications, and PSA considerations. Compounded formulations, where offered, are prepared by state-licensed compounding pharmacies in accordance with FDA regulations and are not FDA-approved. Start your online visit here to connect with a licensed provider.

A Note on Nutrition and Hair Health

March is National Nutrition Month — a timely reminder that no oral medication works in isolation. Peer-reviewed research suggests that adequate dietary protein (targeting roughly 1.2–1.6 g per kilogram of body weight daily in men over 40), sufficient zinc, and an anti-inflammatory dietary pattern — including the Mediterranean diet, rich in omega-3 fatty acids, vegetables, and lean protein — support the follicular microenvironment. While diet alone will not reverse androgenetic alopecia, chronic nutritional deficiency can accelerate shedding. Sleep quality also matters: poor sleep elevates cortisol, which may worsen inflammatory scalp conditions. These are adjuncts, not replacements, for evidence-based pharmacologic treatment when indicated.

Sources

• Kaufman KD et al. Finasteride in the Treatment of Men with Androgenetic Alopecia — Journal of the American Academy of Dermatology — https://pubmed.ncbi.nlm.nih.gov/9777765/
• Eun HC et al. Dutasteride vs Finasteride Randomized Trial — Journal of the American Academy of Dermatology — https://pubmed.ncbi.nlm.nih.gov/24411083/
• Mella JM et al. Network Meta-Analysis of Androgenetic Alopecia Treatments — JAMA Dermatology — https://pubmed.ncbi.nlm.nih.gov/30785708/
• FDA Drug Approval — Finasteride 1mg (Propecia) — U.S. Food and Drug Administration — https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/finasteride-propecia-proscar-information
• FDA Drug Approval — Dutasteride (Avodart) — U.S. Food and Drug Administration — https://www.fda.gov/
• Mediterranean Diet and Men's Health — NIH/National Library of Medicine — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566986/

This article is educational. A licensed provider determines whether you are a candidate after a medical intake.

Ready to start your journey?

Complete your free online visit and see if GLP-1 treatment is right for you.

Get Started

Related Articles

Oral Minoxidil vs Topical: What the Evidence Says

James T. · Jul 1, 2026

Hair Loss Confidence Men Over 40: The Lie I Told Myself

Todd Chrisley · May 10, 2026